L’avis intitulé « Vaccin antigrippal FLUCELVAX : transition du vaccin antigrippal FLUCELVAX, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
eNrtWN1v2jAQf+evQLyb8FFKOwWqjbUb0qoxWrRpL5WxL2Bm7NQfKd1fPyehK52StQ21+tIXFOzL786Xu9/dOTzZrHk9AaWZFINGu9lq1EEQSZlYDBqzyzN01DgZ1sIVTvC9WMfJNdvtRp1wrPWgke4254CFbv44//IR3PugGsNaPZTzFRDzQM4axpufsV6e4ziVqYeJZLS+BrOUdNCIrclW66E2ylkxvJHql44xgTDYruzurq4OdtfDIAV7AqrVoL5gsSgEjVQlTGKVAmFG2MBCqtsSe7uVsJmegpZWEZhgs5womTAKtNh6zDVUUhLd0AtQCQeTKikED1ZkrSuB4xXeTOF6XGz0e7c7MhuDWqjdP+p1+52DTq/breYsteOq4q/gDhHEV93ecavdOw4iFVAgLA1uJDqtTg+1Wt1+QEmgQceQIGrRIYogUQwUygTcCpGcwwIQBcQxWmJrALkfqZjJFjUW7iGWyrgHhKmMTaogFUc4YRoxYZixHFCCCWECOTG2UCyOMUcRtwR4gjfIKJdXLH/V/l80U4oiqdaAri2miiWYQ2oFRlbAdsfcL1MHnRrv3JIGLcvszlXgTCORwqjsfJm2FJ9pKYTzA1SM40nqEO4pgpkePUxCT3oUXD+aKZTpmOPb5krHVV2FFXbboBxV+jtIeoLLNMi489k/+MJyHjzT6tmWWj1ZnDL3SFoXl8UMezat6oiRC3bYlH/RakXBbLaxyEC/HOxvKYoL4sTOOSNV6d8RtAVtZtNxOfu/EefrEOcHrGGm/DHndyaovNEvz8i7GeDJ+ixYeDEoueoc9Q+ODruV6eanS7aSvuXUKhlD4Jia6X0IeCwiuS/1uvwthrrL3rfEfYXEzSYNSZz+klkDVaxYLmPvRiNvnOCPb/KNQtBPp5dVU+mbBXV7kf0thGZ08DcJqpVzHz2CS9xSw59PAzkXeplCrSrm2KUxsX4XBEuscxJoOoJ56xVer1fYaWX93RV46Zfz+SGvuJ5Mn+eN1NMjuSobPdZN7zshbt/fTqKFOoyysMd3yAuXt/IyPn35inU/Hnoze/KAYf2pyUa5jCN8tc12Xoi4X41031WcKUcOX6OIldzblsZlGOR3xsNaGKT3xcPaH+uXnrk=
kGDP0yRNnJAmD2Qh
